Introduction
Pharmacy signboard and name rules in Turkey are an important part of Turkish pharmacy law because a pharmacy is not an ordinary commercial shop. A pharmacy is a regulated healthcare institution that provides medicine supply, prescription services, patient counseling and public health support under the professional responsibility of a pharmacist. For this reason, the name, signboard, exterior appearance, E-logo sign, window display and duty pharmacy notice of a pharmacy are subject to strict rules.
In ordinary commercial life, a business may choose a brand name, install eye-catching signs, use advertising panels, place promotional posters in windows, use digital screens and compete visually with other businesses. Pharmacies are different. Turkish pharmacy law allows pharmacies to identify themselves to the public, but does not allow signboards, banners, window posters or external objects to become tools of unfair competition, product promotion or misleading advertising.
The main legal source is the Regulation on Pharmacists and Pharmacies. Article 25 of the Regulation specifically regulates pharmacy name, signboard and window display. It provides that newly opened or relocated pharmacies cannot use the same name as another pharmacy in the same district; that at least one visible façade must have a standardized illuminated or non-illuminated sign showing the pharmacy name; that an illuminated E-logo sign must be placed on the exterior façade according to standards determined by the Turkish Pharmacists’ Association; and that portable signs, totem signs, posters and similar objects creating unfair competition cannot be placed in front of pharmacies, streets or roads. It also prohibits placing signs or announcements on pharmacy windows for product promotion purposes.
These rules show that pharmacy signage has two legal functions. The first is public accessibility: patients must be able to find the pharmacy easily. The second is professional neutrality: the pharmacy must not use signage as a hidden advertising or competition tool. A legally compliant pharmacy sign should inform, not promote.
Legal Framework of Pharmacy Signboards and Names in Turkey
The legal framework is based primarily on Law No. 6197 on Pharmacists and Pharmacies and the Regulation on Pharmacists and Pharmacies. The Regulation states that its purpose is to determine pharmacists’ duties, powers and responsibilities and to regulate pharmacy opening, operation, relocation, transfer, closure, pharmacy characteristics and pharmacy services. It also defines a pharmacy as a healthcare institution opened under the ownership and responsible management of a pharmacist.
This definition is important. Since a pharmacy is a healthcare institution, not an ordinary store, its signboard cannot be evaluated only under commercial advertising logic. The signboard is part of the public health service environment. It must help patients identify the pharmacy while respecting professional rules, fair competition and patient safety.
The Regulation’s Article 25 is the core provision on pharmacy names, signboards and windows. Article 26 separately regulates the duty pharmacy notice, requiring pharmacies to announce the name, address and telephone information of duty pharmacies in a way that is visible and readable from outside, even when the pharmacy itself is closed.
Pharmacy signboard rules must also be read together with inspection provisions. Pharmacies are inspected at least twice per year and whenever necessary; inspectors determine whether pharmacies comply with applicable legislation. If deficiencies are detected, correction periods may be granted, and unresolved violations may lead to legal action or suspension of the license until deficiencies are corrected.
Pharmacy Name Rules in Turkey
The first rule concerns the name of the pharmacy. Article 25 provides that, for pharmacies opened or relocated after the relevant amendment entered into force, pharmacy names cannot be the same as the names of pharmacies located in the same district.
This rule prevents confusion among patients and protects fair competition between pharmacies. If two pharmacies in the same district use the same or indistinguishably similar names, patients may go to the wrong pharmacy, prescriptions may be confused, delivery or communication errors may occur, and unfair benefit may arise from another pharmacy’s reputation.
The rule is especially important during pharmacy opening, transfer and relocation. A pharmacist should not select a name merely because it is commercially attractive. Before applying for opening or relocation, the pharmacist should check whether the same name already exists in the district. The relevant pharmacy chamber and provincial health directorate practice should also be reviewed.
A safe pharmacy name should be distinctive, simple, non-misleading and compatible with professional dignity. It should not imply official hospital affiliation, public institution status, exclusive authority, superior medical quality, guaranteed treatment, discount promise or commercial campaign.
Misleading Pharmacy Names
Although Article 25 expressly addresses identical names within the same district, the broader professional and administrative framework also requires names not to mislead the public. A pharmacy name should not create the impression that the pharmacy is part of a hospital, clinic, medical center, public authority, university hospital, SGK unit, TİTCK institution or official public service unless that is legally accurate and permitted.
For example, names such as “Official Hospital Pharmacy,” “SGK Pharmacy,” “University Hospital Pharmacy,” “Emergency Prescription Center,” “Cancer Treatment Pharmacy,” or “Government Pharmacy” may create legal concerns if they imply a status that the pharmacy does not have. Similarly, a pharmacy name suggesting specialization in a disease may raise advertising, unfair competition or patient-direction concerns.
A pharmacy name should identify the pharmacy, not market medical superiority. The safest approach is to choose a neutral pharmacy name that does not contain therapeutic claims, disease names, discount language, institutional affiliation or superiority statements.
Signboard Showing the Pharmacy Name
Article 25 requires that at least one visible façade of the pharmacy must have a sign showing the pharmacy’s name, within the boundaries of the place used as the pharmacy. The sign may be illuminated or non-illuminated, but its characteristics must be standardized by the Turkish Pharmacists’ Association.
This rule creates both a positive obligation and a limitation. The positive obligation is that the pharmacy must have a proper sign showing its name. The limitation is that the sign must remain within the pharmacy premises boundaries and must comply with standardization.
This prevents pharmacies from placing name signs far away from the pharmacy, on public streets, on neighboring buildings, on poles, on totems or in places that create unfair visibility compared with other pharmacies. The sign is meant to identify the pharmacy at its actual location. It is not meant to create advertising space.
The sign should therefore be placed on the pharmacy’s visible façade and should be consistent with the standardized design. Before installing a sign, the pharmacist should check current TEB standards, chamber instructions, municipal façade restrictions and building management rules.
Illuminated or Non-Illuminated Pharmacy Sign
Article 25 permits the pharmacy name sign to be illuminated or non-illuminated. However, this does not mean that any type of illuminated advertising sign is allowed. The sign must comply with the standardization determined by the Turkish Pharmacists’ Association and must stay within the legal boundaries.
Illumination should serve identification and patient access. It should not become a flashing advertisement, moving digital billboard, color-changing promotional panel or attention-grabbing commercial campaign. Excessive brightness, animation, product promotions, moving text, discount messages or drug advertisements may create compliance problems.
A pharmacy may need visibility at night, especially if it is on duty. But night visibility must be balanced with the legal purpose of the sign. The safest sign is simple, standardized and informative.
E-Logo Sign Requirement
Article 25 also requires an illuminated sign with the “E” logo on the exterior façade of the pharmacy. The minimum and maximum dimensions and colors are determined according to standards set by the Turkish Pharmacists’ Association. The sign must be placed at a height where it can be easily seen from two sides.
The E-logo sign has a public access function. It allows patients to identify a pharmacy quickly, including in emergencies, at night or in unfamiliar locations. It functions more like a professional public identifier than a commercial logo.
However, the E-logo sign must comply with size, color and placement standards. A pharmacy should not enlarge it excessively, duplicate it unnecessarily, place it in multiple non-standard positions, convert it into a promotional device or combine it with commercial product slogans.
The rule’s purpose is uniformity. If every pharmacy uses different oversized or promotional signs, visual competition increases and the public-health identification function becomes distorted.
Prohibition on Portable, Totem and Street Signs
Article 25 prohibits placing portable signs, totem signs, posters and similar objects in front of pharmacies, on streets or roads where they create unfair competition.
This is a major compliance issue. Pharmacies may want to use sidewalk signs, freestanding boards, direction arrows, banners, balloons, totems, pavement stands or illuminated street objects to attract patients. However, the Regulation restricts such practices because they may create unfair competition between pharmacies and turn healthcare service into visual advertising competition.
A pharmacy should not place signs outside its premises to gain extra visibility. For example, a signboard placed at a street corner directing patients to the pharmacy may be risky. A freestanding illuminated totem in front of the pharmacy may be risky. A banner announcing “open 24 hours,” “discount,” “dermocosmetic campaign,” “all medicines available,” or “nearest pharmacy” may be risky.
The safest approach is to use only the legally permitted façade sign and E-logo sign, plus the duty pharmacy notice required by law.
Pharmacy Window Display Rules
Article 25 prohibits placing signs or announcements on pharmacy windows for product promotion purposes.
This rule is especially important because many pharmacies sell products other than prescription medicines, such as cosmetics, food supplements, medical materials and supportive products. A pharmacy may be tempted to use window posters for campaigns, brand promotions, discounts, seasonal products or health claims. However, the Regulation restricts window use where the purpose is product promotion.
Examples of risky window practices include posters stating “20% discount on vitamins,” “best collagen product,” “flu protection campaign,” “dermocosmetic festival,” “weight loss support,” “pain relief product available,” or product-brand visuals promoting specific items.
The legal point is not only whether the product is a prescription medicine. Even for products that may be sold in pharmacies, window promotion may create unfair competition, advertising or health claim issues. The pharmacy window should not become a retail advertising surface.
Product Promotion and Health Claim Risks
Window displays, signboards and banners may also create health claim risks. If a pharmacy uses claims such as “cures flu,” “stops hair loss,” “treats anxiety,” “protects from cancer,” “guaranteed weight loss,” or “best medicine for pain,” the issue may go beyond signboard rules and become a broader advertising or health-claim violation.
Pharmacies should remember that patients may rely on pharmacy visuals as professional advice. A poster that appears harmless in a normal shop may be legally sensitive in a pharmacy because it can influence medicine or health product choices.
Therefore, pharmacy window and signboard compliance should be reviewed with both pharmacy legislation and product advertising rules in mind. The safest content is neutral identification, not product promotion.
Duty Pharmacy Notice
Article 26 requires pharmacies, even when closed, to announce the name, address and telephone information of duty pharmacies in a way that is visible, easily readable and illuminated or digitally displayed from outside. If a pharmacy keeps its doors closed while providing night duty service, it must have a bell at the door.
This rule serves an important public health function. Patients may need urgent medicine outside ordinary working hours. If a pharmacy is closed, patients must still be able to find the duty pharmacy. Therefore, the duty pharmacy notice is not advertising. It is a legal service notice.
However, duty pharmacy notices must also be neutral. The Regulation separately provides that duty pharmacies cannot make announcements in a way that creates unfair competition.
This means that a pharmacy should not use duty status as a promotional opportunity. A duty notice should not include exaggerated language, product campaigns, discount offers, bright advertising banners or competitive claims. It should simply provide the legally required duty pharmacy information.
Digital Duty Pharmacy Displays
Article 26 allows the duty pharmacy information to be announced in an illuminated or digital environment, provided it is visible and readable from outside.
Digital displays may be practical, but they create risk if used beyond the legal purpose. A digital screen showing duty pharmacy names, addresses and telephone numbers is permissible within the rule. But a digital screen that alternates between duty information and product advertisements, cosmetic campaigns, discount messages, health claims or social media QR codes may violate pharmacy signage and advertising restrictions.
Pharmacies using digital displays should configure them strictly for duty pharmacy information. The content should be stable, readable, non-promotional and regularly updated.
Pharmacy Signs During Closure
Signboard rules also matter during pharmacy closure. Article 48 provides that when a pharmacist voluntarily closes a pharmacy, the provincial health directorate checks medicine procedures, confirms that no medicines remain in the pharmacy, ensures that pharmacy signs are removed, records that the premises has lost pharmacy status and then cancels the license.
This rule shows that a pharmacy sign is legally connected to pharmacy status. Once a pharmacy closes, the signs must be removed because the premises must no longer appear to the public as a pharmacy. Leaving pharmacy signs after closure may mislead patients and create public health risk.
The same issue may arise in relocation or transfer. If a pharmacy relocates, the old premises should not continue to display pharmacy signs. If a pharmacy changes name or ownership, the signage should be updated according to the approved status.
Signboard Rules in Pharmacy Relocation
Relocation creates a new signboard compliance stage. Article 25’s identical-name prohibition applies to pharmacies opened or relocated after the relevant amendment. It states that such pharmacies cannot use the same name as pharmacies in the district where the pharmacy will open.
A pharmacist relocating to another district should therefore re-check name availability. A name that was lawful in the previous district may be unavailable in the new district if another pharmacy already uses it there.
Relocation also requires physical signboard compliance at the new premises. The new façade, building structure, municipal rules, condominium management plan and TEB standards should be reviewed before installation. If the pharmacy uses a non-compliant sign after relocation, inspection issues may arise.
Signboard Rules in Pharmacy Transfer
In pharmacy transfer, the buyer pharmacist may want to keep the existing pharmacy name because the name may have commercial recognition. This may be possible if the name remains legally compliant and there is no misleading element. However, the parties should verify whether the name and signboard remain compatible with the license, transfer records and professional rules.
If the pharmacy’s name contains the previous pharmacist’s personal name, the buyer should consider whether continued use is appropriate and legally documented. If the name creates confusion or misrepresents ownership, it may be risky. The signboard should be updated where necessary to reflect the approved pharmacy name.
The transfer agreement should include a clause on signboard ownership, removal, update costs, E-logo sign, window materials and compliance responsibility. If the seller leaves non-compliant promotional materials, the buyer should remove them before taking over operations.
Lease and Building Management Issues
Pharmacy signboards are also affected by lease agreements and building management rules. A pharmacist may have pharmacy law permission to install a sign, but the lease may contain restrictions on façade use, illuminated signs, exterior installations, drilling, electricity connections or common area use.
Before signing a pharmacy lease, the pharmacist should ensure that the landlord permits all legally required pharmacy signage, including the pharmacy name sign, E-logo sign and duty pharmacy notice. The lease should state that the premises will be used as a pharmacy and that the tenant may install all signage required or permitted by pharmacy legislation, subject to applicable approvals.
If the building is in a shopping mall, medical plaza, protected area, historical building or condominium complex, additional restrictions may apply. These should be reviewed before installation. The pharmacist should avoid a situation where the pharmacy is licensed but cannot display required signs because of private-law restrictions.
Municipal Signboard Rules and Pharmacy Law
Municipalities may have rules on signboard taxes, façade appearance, illuminated signs, advertising boards, historical areas, pavement occupation and urban aesthetics. Pharmacy signboards must therefore satisfy both pharmacy legislation and local administrative requirements.
However, pharmacy law remains central because it determines what a pharmacy sign may contain and what signs are prohibited. A municipality’s general permission for a commercial sign does not automatically make that sign compliant with pharmacy law. For example, a municipality might allow a general business banner, but pharmacy law may still prohibit promotional window posters or unfair competition signs.
The pharmacist should therefore treat municipal approval as one layer of compliance, not the entire legal review.
Advertising Ban and Professional Ethics
Pharmacy signboard rules are closely connected to advertising restrictions and professional ethics. The İstanbul Chamber of Pharmacists’ evaluation on advertising and social media emphasizes that pharmacy advertising is restricted under professional rules and that chambers have authority to intervene in advertisements and conduct contrary to professional ethics and fair competition.
This is relevant because signboards often become a disguised form of advertising. A pharmacy may not directly say “advertisement,” but a window poster, sidewalk board, oversized sign, discount message or product banner may function as advertising.
A legally compliant pharmacy should therefore ask: Does this sign merely identify the pharmacy, or does it promote the pharmacy or a product? Does it help patients find the pharmacy, or does it create unfair competition? Does it provide necessary information, or does it influence consumer choice through health claims or discounts?
If the answer shows promotional purpose, the sign should not be used.
Hospital and Clinic Affiliation Claims
Pharmacies near hospitals, clinics and medical centers should be especially careful. A signboard or name suggesting hospital affiliation can mislead patients and create prescription referral concerns. Words such as “hospital pharmacy,” “clinic pharmacy,” “official pharmacy,” “doctor pharmacy,” “emergency hospital prescription pharmacy,” or similar expressions may create legal risk if not accurate and permitted.
Turkish pharmacy law prohibits prescription steering and hidden cooperation with healthcare institutions or physicians. A signboard suggesting an exclusive relationship with a hospital may support allegations of patient direction or unfair competition.
A pharmacy near a hospital may lawfully serve patients who freely choose it. But its name and signboard should remain neutral. It should not appear to be an official unit of the hospital or a pharmacy endorsed by doctors unless the legal status truly supports that wording.
Social Media, QR Codes and Digital Signage
Modern pharmacies may want to place QR codes, Instagram handles, WhatsApp numbers or website links on signs and windows. This is legally sensitive. The Regulation prohibits websites being opened in the name of pharmacies and pharmacy pharmacists, and it prohibits online sale of medicines and certain pharmacy-exclusive products.
A QR code leading to a product catalogue, medicine order page, prescription upload form, WhatsApp ordering system or promotional social media page may create serious compliance risk. Even if the physical sign looks simple, the digital destination may violate online sale or advertising restrictions.
If a pharmacy uses digital contact information, it should ensure that it does not create an online medicine sale channel, prescription collection system or product promotion platform. The safest approach is to avoid QR-code marketing on pharmacy windows and signs unless the content has been legally reviewed.
Signboard Compliance and Unfair Competition
Article 25 expressly connects certain signs to unfair competition by prohibiting portable signs, totem signs, posters and similar objects that create unfair competition.
Unfair competition in pharmacy practice is more sensitive than ordinary commercial competition. Pharmacies compete within a healthcare profession. Excessive signage, aggressive visibility tactics, product promotions, discount signs, hospital-direction signs or duty pharmacy announcements used as marketing can distort professional equality and patient choice.
A pharmacy should compete through lawful service quality, professional counseling, stock management, accessibility and patient trust, not through illegal visual advertising. Signboard compliance is therefore part of professional discipline.
Inspection of Pharmacy Signboards
Pharmacy signboards, window displays and duty notices may be inspected. Article 47 provides that pharmacies are inspected at least twice per year and whenever necessary, and that inspectors check compliance with applicable legislation according to the inspection form. If deficiencies are found, correction periods are granted; unresolved violations may lead to action under Law No. 6197 and, if violations persist despite sanctions, license suspension until correction.
During an inspection, authorities may check whether the pharmacy name is compliant, whether the name sign follows TEB standards, whether the E-logo sign is placed correctly, whether prohibited portable or totem signs are used, whether the window contains product promotional posters, whether the duty pharmacy notice is visible and readable, and whether closed or relocated premises still display pharmacy signs.
A pharmacy should therefore periodically review its exterior and windows. Signboard compliance should not be checked only at opening. Seasonal posters, campaign materials or supplier-provided visuals may create later violations.
Administrative Consequences
Non-compliance with signboard and name rules may lead to inspection findings, correction orders, administrative action, professional disciplinary review and, in persistent cases, license-related consequences. The exact consequence depends on the violation and whether it is corrected within the given period.
For example, a minor signboard format deficiency may be corrected after a warning. But repeated refusal to remove prohibited promotional materials, totem signs or unfair competition objects may lead to stronger measures. If signboard irregularity is connected to misleading advertising, prescription steering, unlawful online sale or health claims, additional legal risks may arise.
The inspection framework allows deficiencies to be corrected within a period, but unresolved violations may lead to action and possible license suspension until correction.
Civil and Professional Liability
Although signboard violations are often administrative, they may also create civil or professional consequences. If a misleading name causes patient confusion, if a hospital-affiliation claim misleads patients, if product promotions cause inappropriate use, or if a window claim leads to consumer harm, liability questions may arise.
Professional disciplinary liability may also arise because pharmacists are expected to act in accordance with professional dignity, ethics and fair competition. Signage that creates unfair competition or advertising may be reviewed by pharmacy chambers.
Pharmacies should therefore treat signage as a legal compliance area, not merely as design or marketing.
Practical Compliance Checklist
A pharmacy should apply the following checklist:
Check whether the pharmacy name is unique within the district for opening or relocation.
Avoid names implying hospital, clinic, SGK, state, university or official affiliation unless legally accurate.
Use a standardized pharmacy name sign on at least one visible façade.
Keep the sign within the pharmacy premises boundaries.
Install the E-logo illuminated sign according to TEB standards.
Avoid portable signs, totem signs, banners, posters and similar objects in streets or in front of the pharmacy.
Do not place product promotion signs or announcements on windows.
Use duty pharmacy notices only for legally required duty information.
Ensure duty pharmacy information is visible, readable and illuminated or digitally displayed from outside.
Do not use duty status for promotional announcements.
Remove pharmacy signs after closure or relocation.
Review social media handles, QR codes and digital screens for online sale or advertising risk.
Check lease and building management permission before installation.
Preserve records of signboard approval and compliance where possible.
Review exterior signage periodically before inspections.
Common Mistakes
The first common mistake is choosing a pharmacy name already used in the same district.
The second mistake is installing oversized, non-standard or excessive signs.
The third mistake is placing totem signs, sidewalk boards or movable advertising objects outside the pharmacy.
The fourth mistake is using windows for product promotion, discounts, brand campaigns or health claims.
The fifth mistake is using hospital or clinic-related names that imply official affiliation.
The sixth mistake is using digital screens for product advertisements instead of only duty pharmacy information.
The seventh mistake is leaving old pharmacy signs after closure or relocation.
The eighth mistake is assuming that municipal sign approval is enough even if pharmacy law prohibits the content or format.
The ninth mistake is placing QR codes or social media links that lead to medicine ordering or product promotion.
The tenth mistake is using duty pharmacy status as advertising.
Frequently Asked Questions
Can two pharmacies in the same district have the same name?
No. For pharmacies opened or relocated after the relevant amendment, pharmacy names cannot be the same as pharmacies located in the same district.
Is a pharmacy required to have a signboard?
Yes. At least one visible façade must have an illuminated or non-illuminated standardized sign showing the pharmacy name, within the boundaries of the pharmacy premises.
Is the E-logo sign mandatory?
Yes. The Regulation requires an illuminated E-logo sign on the exterior façade according to dimensions and colors determined by the Turkish Pharmacists’ Association, placed at a height easily visible from two sides.
Can a pharmacy use portable signs or totem signs?
No, pharmacies cannot place portable signs, totem signs, posters or similar objects in front of the pharmacy, on streets or roads in a way that creates unfair competition.
Can pharmacies place product advertisements on windows?
No. The Regulation prohibits placing signs or announcements on pharmacy windows for product promotion purposes.
Must pharmacies display duty pharmacy information?
Yes. Even when closed, pharmacies must announce the name, address and telephone information of duty pharmacies in a visible, easily readable and illuminated or digital form from outside.
Conclusion
Pharmacy signboard and name rules in Turkey are designed to balance patient access, professional identity, fair competition and public health. Pharmacies must be visible and identifiable, but they must not use names, signs, windows or digital displays as advertising tools.
The key rules are clear. A newly opened or relocated pharmacy cannot use the same name as another pharmacy in the same district. At least one visible façade must contain a standardized sign showing the pharmacy name. The exterior façade must include an illuminated E-logo sign according to standards determined by the Turkish Pharmacists’ Association. Portable signs, totem signs, posters and similar objects creating unfair competition are prohibited, and pharmacy windows cannot be used for product promotion.
Duty pharmacy information is separately regulated. Pharmacies must display duty pharmacy name, address and telephone details in a way visible and readable from outside, even when closed, but duty pharmacies cannot use duty service as unfair advertising.
For pharmacists, the safest approach is simple: signage should identify the pharmacy, not promote products or create unfair competition. Pharmacy names should be neutral and non-misleading. Signboards should follow TEB standards. Windows should not be used for campaigns or health claims. Digital signs should not become advertising screens. Pharmacy signs should be removed when the pharmacy closes or relocates.
In Turkey, pharmacy signage is not merely a design issue. It is a legal compliance matter connected to licensing, inspection, professional ethics, advertising restrictions and patient trust. A legally compliant pharmacy signboard protects both the public and the pharmacist by ensuring that the pharmacy is visible, professional, standardized and free from misleading commercial promotion.
Yanıt yok